On Monday the Supreme Court resumed the hearing session relating the use of unregistered stents and issued notices to eight private and public hospitals instructing them to submit details relating the purchase of stents by them in the last three months.
Chief Justice Mian Saqib Nisar heading a three-member bench summoned the heads of the following organizations:
- Punjab Institute of Cardiology (PIC) Lahore,
- Shifa International Hospital Islamabad,
- Rawalpindi Institute of Cardiology (RIC),
- Kulsoom International Hospital Islamabad,
- Quaid-e-Azam International Hospital Rawalpindi,
- Agha Khan Hospital Karachi,
- Pakistan Institute of Medical Sciences (PIMS) Islamabad, and,
- National Institute of Cardiovascular Diseases (NIC) Karachi
The heads of the mentioned institutes are to appear before the court on Saturday along with the reports relating the stent packages used in angioplasty.
Also Read: SC Removes Ban on 3 Mineral Water Brands
While hearing the session the chief justice mentioned that when would this good news be revealed that Pakistan has started the production of its own stents locally.
Upon the remark of the chief justice the heart specialist Dr Murtaza told the court that Pakistan would start producing the cardiac stents by June 2018.
The chief justice said that indeed this is good news that the Pakistani stents are soon to make their way into markets. He emphasized that all efforts should be put in to try making the stents come in the market earlier than the June 2018 defined time.
The chief justice also inquired about the price of the stent, to which Dr Murtaza answered that it would have cost around fifteen thousand per piece.
Muhammad Waqar Rana—Additional Attorney General (AAG) told the court that at least seventy-two companies dealing in stents are registered in Pakistan.
To this, the chief justice asked him to share the detailed information with the court if he has got the verification done.
The chief justice mentioned that the court is trying to make sure that people should receive inexpensive and good quality treatment facilities.
The AAG also informed the court that the stents worth rupees seventy thousand apiece are being sold at the cost of one lac ten thousand in the market.
To this the chief justice remarked that it is not good and unjustifiable to take the benefit of patients’ misery and situation, he added that the situation could be improved if four to five people are punished.
More Read: School Children to Experience Drug Tests